Related Experiment Video
Updated: Feb 20, 2026

Intravascular Delivery of Biologics to the Rat Kidney
Published on: September 1, 2016
Why is buprenorphine coformulated with naloxone?
1Eric Urnoski is a clinical pharmacist in critical care at Crozer-Chester Medical Center in Upland, Pa. The author has disclosed no potential conflicts of interest, financial or otherwise.
Abstract:
Combination buprenorphine-naloxone is a cornerstone of outpatient treatment for substance use disorder, and is more widely accessible in primary care. Because oral buprenorphine has been diverted and abused for its euphoric properties, a combination formulation was developed and will trigger withdrawal symptoms if injected IV.
More Related Videos
13:18Optimization of the Longa Middle Cerebral Artery Occlusion Method for Complete Reperfusion
Published on: November 22, 2024
11:02Author Spotlight: Investigating Cellular and Molecular Dynamics During Muscle Regeneration Using Cutting-Edge Single-Cell Technologies
Published on: December 1, 2023
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Analgesia and Pain Management
Bioequivalence studies: Biowaivers
Opioid Receptors: Overview
Oral Drug Delivery Systems: Continuous-Release Systems